Second-trimester soft markers: Relation to first-trimester nuchal translucency in unaffected pregnancies

Ultrasound in Obstetrics and Gynecology

Volumn 39, Issue 3, 2012, Pages 274-278

  Miguelez, J ^a   De Lourdes Brizot, M ^a   Liao, A W ^a   De Carvalho, M H B ^a   Zugaib, M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Down syndrome; nuchal translucency; prenatal; sequential screening; soft markers; sonography

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD; COHORT ANALYSIS; DOWN SYNDROME; ECHOGRAPHY; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; METHODOLOGY; NASAL BONE; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE; PREGNANCY; PRENATAL DEVELOPMENT; PROSPECTIVE STUDY; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY;

ADULT; BIOLOGICAL MARKERS; COHORT STUDIES; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; NASAL BONE; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES; RISK ASSESSMENT; ULTRASONOGRAPHY, PRENATAL;

EID: 84857912829     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.9024     Document Type: Article

References (30)

1. Bindra R, Heath V, Liao A, Spencer K, Nicolaides KH,. One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies. Ultrasound Obstet Gynecol 2002; 20: 219-225.
2. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Dar P, Dugoff L, Craigo SD, Timor IE, Carr SR, Wolfe HM, Dukes K, Canick JA, Malone FD,. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005; 353: 2001-2011. (Pubitemid 41609093)
3. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007; 109: 217-227.
4. Nicolaides KH,. Screening for chromosomal defects. Ultrasound Obstet Gynecol 2003; 21: 313-321. (Pubitemid 36555106)
5. Nyberg DA, Souter VL, El-Bastawissi A, Young S, Luthhardt F, Luthy DA,. Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy. J Ultrasound Med 2001; 20: 1053-1063. (Pubitemid 32937496)
6. Bromley B, Lieberman E, Shipp TD, Benacerraf BR,. The genetic sonogram: a method of risk assessment for Down syndrome in the second trimester. J Ultrasound Med 2002; 21: 1087-1096; quiz 1097-1098.
7. Krantz DA, Hallahan TW, Macri VJ, Macri JN,. Genetic sonography after first-trimester Down syndrome screening. Ultrasound Obstet Gynecol 2007; 29: 666-670. (Pubitemid 46975104)
8. Salomon LJ, Chevret S, Bussieres L, Ville Y, Rozenberg P,. Down syndrome screening using first-trimester combined tests and contingent use of femur length at routine anomaly scan. Prenat Diagn 2010; 30: 783-789.
9. Aagaard-Tillery KM, Malone FD, Nyberg DA, Porter TF, Cuckle HS, Fuchs K, Sullivan L, Comstock CH, Saade GR, Eddleman K, Gross S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Bianchi DW, D'Alton ME,; First and Second Trimester Evaluation of Risk Research Consortium. Role of second-trimester genetic sonography after Down syndrome screening. Obstet Gynecol 2009; 114: 1189-1196.
10. Rozenberg P, Bussieres L, Chevret S, Bernard JP, Malagrida L, Cuckle H, Chabry C, Durand-Zaleski I, Bidat L, Lacroix I, Moulis M, Roger M, Jacquemot MC, Bault JP, Boukobza P, Boccara P, Vialat F, Giudicelli Y, Ville Y,. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population. Am J Obstet Gynecol 2006; 195: 1379-1387. (Pubitemid 44740408)
11. Atzei A, Gajewska K, Huggon IC, Allan L, Nicolaides KH,. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype. Ultrasound Obstet Gynecol 2005; 26: 154-157. (Pubitemid 41540299)
12. Prefumo F, Presti F, Thilaganathan B, Carvalho JS,. Association between increased nuchal translucency and second trimester cardiac echogenic foci. Obstet Gynecol 2003; 101: 899-904. (Pubitemid 36561251)
13. Salomon LJ, Bernard JP, Taupin P, Benard C, Ville Y,. Relationship between nuchal translucency at 11-14 weeks and nuchal fold at 20-24 weeks of gestation. Ultrasound Obstet Gynecol 2001; 18: 636-637. (Pubitemid 34063065)
14. Pandya PP, Snijders RJ, Johnson S, Nicolaides KH,. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness. Ultrasound Obstet Gynecol 1995; 5: 381-383.
15. Maymon R, Zimerman AL, Weinraub Z, Herman A, Cuckle H,. Correlation between nuchal translucency and nuchal skin-fold measurements in Down syndrome and unaffected fetuses. Ultrasound Obstet Gynecol 2008; 32: 501-505.
16. Miguelez J, Moskovitch M, Cuckle H, Zugaib M, Bunduki V, Maymon R,. Model-predicted performance of second-trimester Down syndrome screening with sonographic prenasal thickness. J Ultrasound Med 2010; 29: 1741-1747.
17. th edn), Milunsky A, Milunsky JM, (eds). Wiley-Blackwell: Oxford, 2010; 771-818.
18. Maymon R, Levinsohn-Tavor O, Cuckle H, Tovbin Y, Dreazen E, Wiener Y, Herman A,. Second trimester ultrasound prenasal thickness combined with nasal bone length: a new method of Down syndrome screening. Prenat Diagn 2005; 25: 906-911. (Pubitemid 41494986)
19. Persico N, Borenstein M, Molina F, Azumendi G, Nicolaides KH,. Prenasal thickness in trisomy-21 fetuses at 16-24 weeks of gestation. Ultrasound Obstet Gynecol 2008; 32: 751-754.
20. Nicolaides KH,. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004; 191: 45-67. (Pubitemid 39077955)
21. Hadlock FP, Shah YP, Kanon DJ, Lindsey JV,. Fetal crown-rump length: reevaluation of relation to menstrual age (5-18 weeks) with high-resolution real-time US. Radiology 1992; 182: 501-505.
22. Bunduki V, Ruano R, Miguelez J, Yoshizaki CT, Kahhale S, Zugaib M,. Fetal nasal bone length: reference range and clinical application in ultrasound screening for trisomy 21. Ultrasound Obstet Gynecol 2003; 21: 156-160. (Pubitemid 36286602)
23. Reynolds T,. Screening by test combination: a statistical overview. In Screening for Down's Syndrome, Grudzinskas JG, Chard T, Chapman M, Cuckle H, (eds). Cambridge University Press: Cambridge, 1994; 47-71.
24. Reynolds TM, Penney MD,. The mathematical basis of multivariate risk screening: with special reference to screening for Down's syndrome associated pregnancy. Ann Clin Biochem 1990; 27: 452-458. (Pubitemid 20340290)
25. Cohen J,. A power primer. Psychol Bull 1992; 112: 155-159.
26. Wright D, Kagan KO, Molina FS, Gazzoni A, Nicolaides KH,. A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol 2008; 31: 376-383.
27. Lau TK, Evans MI,. Second-trimester sonographic soft markers: what can we learn from the experience of first-trimester nuchal translucency screening? Ultrasound Obstet Gynecol 2008; 32: 121-125.
28. Benn PA, Kaminsky LM, Ying J, Borgida AF, Egan JF,. Combined second-trimester biochemical and ultrasound screening for Down syndrome. Obstet Gynecol 2002; 100: 1168-1176. (Pubitemid 35449182)
29. Borrell A, Mercade I, Casals E, Borobio V, Seres A, Soler A, Fortuny A, Cuckle H,. Combining fetal nuchal fold thickness with second-trimester biochemistry to screen for trisomy 21. Ultrasound Obstet Gynecol 2007; 30: 941-945.
30. Morris JK, Wald NJ,. The effect of correlations between screening markers on screening performance. J Med Screen 2007; 14: 151-157. (Pubitemid 47511125)